213 related articles for article (PubMed ID: 8228801)
41. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
[TBL] [Abstract][Full Text] [Related]
42. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen.
Garrone P; Galibert L; Rousset F; Fu SM; Banchereau J
J Immunol; 1994 May; 152(9):4282-90. PubMed ID: 7512590
[TBL] [Abstract][Full Text] [Related]
43. [B lymphocytes of patients with complete IgA deficiency secrete IgA in response to interleukin 10].
Brière F; Chevet D; Bridon JM; Souillet G; Rifle G; Banchereau J
Nephrologie; 1996; 17(5):289-95. PubMed ID: 8927208
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
Blanchard DA; Affredou MT; Vazquez A
J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
[TBL] [Abstract][Full Text] [Related]
45. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
46. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
47. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes.
Punnonen J; Cocks BG; Carballido JM; Bennett B; Peterson D; Aversa G; de Vries JE
J Exp Med; 1997 Mar; 185(6):993-1004. PubMed ID: 9091591
[TBL] [Abstract][Full Text] [Related]
48. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
Burdin N; Van Kooten C; Galibert L; Abrams JS; Wijdenes J; Banchereau J; Rousset F
J Immunol; 1995 Mar; 154(6):2533-44. PubMed ID: 7533177
[TBL] [Abstract][Full Text] [Related]
49. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
[TBL] [Abstract][Full Text] [Related]
50. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
Yoshizaki K; Nakagawa T; Kaieda T; Muraguchi A; Yamamura Y; Kishimoto T
J Immunol; 1982 Mar; 128(3):1296-301. PubMed ID: 6799573
[TBL] [Abstract][Full Text] [Related]
51. Human recombinant IL-3 is a growth factor for normal B cells.
Xia X; Li L; Choi YS
J Immunol; 1992 Jan; 148(2):491-7. PubMed ID: 1729368
[TBL] [Abstract][Full Text] [Related]
52. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
53. Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor.
Emmrich F; Moll H; Simon MM
Immunobiology; 1985 Feb; 169(1):97-102. PubMed ID: 3921456
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
Defrance T; Vanbervliet B; Aubry JP; Banchereau J
J Exp Med; 1988 Oct; 168(4):1321-37. PubMed ID: 3262709
[TBL] [Abstract][Full Text] [Related]
55. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
56. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2).
Splawski JB; McAnally LM; Lipsky PE
J Immunol; 1990 Jan; 144(2):562-9. PubMed ID: 2295801
[TBL] [Abstract][Full Text] [Related]
57. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
Defrance T; Vanbervliet B; Durand I; Banchereau J
Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
[TBL] [Abstract][Full Text] [Related]
58. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10.
Eisenstein EM; Chua K; Strober W
J Immunol; 1994 Jun; 152(12):5957-68. PubMed ID: 7515919
[TBL] [Abstract][Full Text] [Related]
59. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
Yoon HJ; Sugamura K; Loughran TP
Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047
[TBL] [Abstract][Full Text] [Related]
60. Interleukin 1 (IL-1 alpha and IL-1 beta) induces differentiation/activation of B cell chronic lymphoid leukemia cells.
Takeuchi H; Katayama I
Cytokine; 1994 May; 6(3):243-6. PubMed ID: 8054479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
